← All trials
NCT03472014
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 22, 2010
- Primary completion
- Nov 14, 2014
- Completion date
- Nov 14, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bavarian NordicLead sponsor
- Palo Alto Medical FoundationOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.